相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation
Elisabeth G. Klompenhouwer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
R. K. Kelley et al.
ANNALS OF ONCOLOGY (2017)
Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue
Wenjun Wang et al.
JOURNAL OF HEPATOLOGY (2015)
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma
Beom Kyung Kim et al.
JOURNAL OF HEPATOLOGY (2015)
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
Xavier Adhoute et al.
JOURNAL OF HEPATOLOGY (2015)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong-Won Park et al.
LIVER INTERNATIONAL (2015)
Assessment for Retreatment (ART) Score for Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
Masatoshi Kudo et al.
HEPATOLOGY (2014)
Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization
Masafumi Ikeda et al.
JOURNAL OF GASTROENTEROLOGY (2014)
被撤回的出版物: Clinical significance of the best response during repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma (Retracted article. See vol. 62, pg. 252, 2015)
Jonggi Choi et al.
JOURNAL OF HEPATOLOGY (2014)
Long-term outcomes of second treatment after initial transarterial chemoembolization in patients with hepatocellular carcinoma
Young-Il Kim et al.
LIVER INTERNATIONAL (2014)
The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
Wolfgang Sieghart et al.
HEPATOLOGY (2013)
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
Zhen-Wei Peng et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Eun Suk Jung et al.
JOURNAL OF HEPATOLOGY (2013)
Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
D. Y. Kim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization
Jin-Kyu Kang et al.
CANCER (2012)
Response rate and clinical outcome of HCC after first and repeated cTACE performed on demand
E. Terzi et al.
JOURNAL OF HEPATOLOGY (2012)
Lack of Response after Initial Chemoembolization for Hepatocellular Carcinoma: Does It Predict Failure of Subsequent Treatment?
Christos Georgiades et al.
RADIOLOGY (2012)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Selection of important variables and determination of functional form for continuous predictors in multivariable model building
Willi Sauerbrei et al.
STATISTICS IN MEDICINE (2007)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
A randomized clinical trial comparing autologous blood clot and gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma
PCH Kwok et al.
JOURNAL OF HEPATOLOGY (2000)
Transarterial chemoembolization for hepatocellular carcinoma: Volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success - Results from a liver transplantation center
TJ Vogl et al.
RADIOLOGY (2000)